Research programme: photo induced nanoparticle-based therapeutics - Keystone Nano

Drug Profile

Research programme: photo induced nanoparticle-based therapeutics - Keystone Nano

Alternative Names: KN 10; Photo immuno nano therapy - Keystone Nano; Photo induced nanoparticle therapy programme - Keystone Nano; Photo-immuno nanoparticle therapy - Keystone Nano; PINT

Latest Information Update: 12 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Keystone Nano
  • Class Antineoplastics; Calcium compounds; Immunotherapies; Phosphates
  • Mechanism of Action Immunostimulants; Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Cancer

Highest Development Phases

  • Preclinical Lung cancer

Most Recent Events

  • 26 Oct 2016 Photo induced nanoparticle-based therapeutics programme of Keystone Nano is available for licensing as of 26 Oct 2016.
  • 26 Oct 2016 Preclinical trials in Lung cancer in USA (Parenteral) (Keystone Nano website, October 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top